Cargando…
Bladder cancer organoids as a functional system to model different disease stages and therapy response
Bladder Cancer (BLCa) inter-patient heterogeneity is the primary cause of treatment failure, suggesting that patients could benefit from a more personalized treatment approach. Patient-derived organoids (PDOs) have been successfully used as a functional model for predicting drug response in differen...
Autores principales: | Minoli, Martina, Cantore, Thomas, Hanhart, Daniel, Kiener, Mirjam, Fedrizzi, Tarcisio, La Manna, Federico, Karkampouna, Sofia, Chouvardas, Panagiotis, Genitsch, Vera, Rodriguez-Calero, Antonio, Compérat, Eva, Klima, Irena, Gasperini, Paola, Kiss, Bernhard, Seiler, Roland, Demichelis, Francesca, Thalmann, George N., Kruithof-de Julio, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113240/ https://www.ncbi.nlm.nih.gov/pubmed/37072390 http://dx.doi.org/10.1038/s41467-023-37696-2 |
Ejemplares similares
-
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
por: Minoli, Martina, et al.
Publicado: (2020) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021) -
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations
por: Fedrizzi, Tarcisio, et al.
Publicado: (2021) -
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
por: Bonollo, Francesco, et al.
Publicado: (2020) -
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020)